Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
BDXN (Bondex) Volatility at 41.2% in 24 Hours: Trading Volume Soars Amid Panic Selling

BDXN (Bondex) Volatility at 41.2% in 24 Hours: Trading Volume Soars Amid Panic Selling

Bitget PulseBitget Pulse2026/03/18 16:02
Show original
By:Bitget Pulse

Volatility Brief

In the past 24 hours, BDXN price rebounded from a low of $0.00330 to a high of $0.00466, with the current quote at $0.00348, reflecting a fluctuation range of 41.2%. The 24-hour trading volume is approximately $2.92–4 million, which is significantly larger than usual.

Analysis of Abnormal Movement Causes

- There have been no official announcements, major news, or significant on-chain whale transfer records in the past 24 hours.

- Trading volume surged abnormally by 2.8–10.5 times, accompanied by a sharp price drop, suggesting possible panic selling or distribution by smart money.

Market Views and Outlook

Market sentiment is bearish, with trading signals indicating further downward pressure and a potential test of the $0.0033 support. Community views see this as a distribution phase; it is advised to wait for a confirmed rebound before taking action, and to be cautious of high-volatility false breakouts.

Note: This analysis is automatically generated by AI based on public data and on-chain monitoring and is for informational reference only.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Novo Nordisk (NVO.US) unveils $23 billion pipeline blueprint, but the market isn't buying it! Investors ask, "How to turn the tide against adversity?"

After being surpassed by Eli Lilly in the obesity market, Novo Nordisk failed to present a concrete turnaround plan to CEO Mike Doustdal, disappointing investors. The company has pledged to launch more than five blockbuster drugs in the coming years and achieve over $23 billion in new sales, but the press conference lacked details on how to drive growth.

智通财经2026/09/21 09:31
Novo Nordisk (NVO.US) unveils $23 billion pipeline blueprint, but the market isn't buying it! Investors ask, "How to turn the tide against adversity?"

STONK hits new highs after erasing 27% crash

Cryptopolitan2026/09/21 09:30
STONK hits new highs after erasing 27% crash

25 Days, Four Launches in Sight! Rocket Lab (RKLB.US) Accelerates Rocket Launches to Advance Its Ambitious "Space AI Infrastructure" Goals

After another successful mission, Rocket Lab's 97th Electron rocket is now positioned at the launch pad. This flight will be Rocket Lab's fourth launch in 25 days and its 18th launch in 2026.

智通财经2026/09/21 08:41